학술논문

The epidemiology of glioma in adults: a “state of the science” review
Document Type
article
Source
Neuro-Oncology. 16(7)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Orphan Drug
Neurosciences
Prevention
Genetics
Cancer
Human Genome
Brain Disorders
Brain Cancer
Rare Diseases
Adult
Brain Neoplasms
Glioma
Humans
Risk Factors
brain tumors
epidemiology
genome-wide association studies
glioma
risk factors
Oncology & Carcinogenesis
Oncology and carcinogenesis
Language
Abstract
Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome. Genomic analyses of glioma have also produced new evidence about risk and prognosis. Recently discovered biomarkers that indicate improved survival include O⁶-methylguanine-DNA methyltransferase methylation, isocitrate dehydrogenase mutation, and a glioma cytosine-phosphate-guanine island methylator phenotype. Genome-wide association studies have identified heritable risk alleles within 7 genes that are associated with increased risk of glioma. Many risk factors have been examined as potential contributors to glioma risk. Most significantly, these include an increase in risk by exposure to ionizing radiation and a decrease in risk by history of allergies or atopic disease(s). The potential influence of occupational exposures and cellular phones has also been examined, with inconclusive results. We provide a “state of the science” review of current research into causes and risk factors for gliomas in adults.